Pharma Focus Europe

Europe's pharma supply chain faces growing pressure from parallel trade and medicine shortages. Explore new EU rules, export restrictions, and strategies for strengthening supply resilience. pharmafocuseurope.com/articl… #Pharma #SupplyChain

Beyond GLP-1: Explore emerging biologics, long-acting therapies, and new approaches to chronic disease care, alongside Europe's evolving regulatory and reimbursement landscape. pharmafocuseurope.com/articl… #Biologics #Pharma

Process validation is a lifecycle commitment, not a one-time exercise. Explore continued process verification, automation, and Europe's evolving GMP Annex 15 expectations for drug manufacturers. pharmafocuseurope.com/articl… #GMP #pharmamar

What does it take to make a bioprocess reproducible from one run to the next? Discover Multifors 3 and what it means for reproducible process development: infors-ht.com/en/products/bi… #Bioprocessing

How do analytical strategies evolve from pharmaceutical development to manufacturing? Explore process understanding and scale-up in our latest Pharma Focus Europe Video Byte Interview featuring Parag Borgaonkar of Thermo Fisher Scientific. pharmafocuseurope.com/thermo… #Pharma

Ready to take your 3D cell culture workflows to the next level? Explore practical pipetting resources from Sartorius to help you prepare 3D cell cultures with confidence and consistency. 🔗 Explore the resources and optimize your workflow! sartorius.com/en/products/pi…

European pharma risk management is key to supply chain resilience, operational risk control and business continuity. Learn how pharma companies can strengthen drug supply security. pharmafocuseurope.com/articl… #Pharma #SupplyChain

𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲-𝐃𝐫𝐮𝐠 𝐂𝐨𝐧𝐣𝐮𝐠𝐚𝐭𝐞𝐬 are transforming cancer care in Europe! Discover how ADC innovations are advancing targeted therapies, improving survival outcomes and shaping the future of oncology. 🔗 pharmafocuseurope.com/articl… #ADC #Oncology

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

ADCs, peptides & advanced therapies are driving investment in specialised capabilities, sterile manufacturing and integrated pharma services. 🔗 pharmafocuseurope.com/articl… #CDMO #Pharmaceuticals

New exclusivity rules, comparative evidence incentives & faster assessments could reshape drug development and market access across Europe. 🔗 pharmafocuseurope.com/articl… #Pharma #DrugDevelopment

Advanced technologies, green chemistry & critical medicines policies are creating new opportunities for high-value API production and stronger pharma supply chains. 🔗 pharmafocuseurope.com/articl… #APIManufacturing #Pharmatwt

With ~100 biologics losing EU exclusivity by 2032, streamlined regulations and untapped markets are opening new doors for manufacturers. 🔗 pharmafocuseurope.com/articl… #Biosimilars #Pharmatwt

How can pharma companies succeed in Europe? Strategic pricing, market access planning, and informed investment decisions are key to navigating diverse healthcare systems and building sustainable growth. Read more: pharmafocuseurope.com/articl… #Pharma #MarketAccess

Sterile API manufacturing is evolving through closed processing, isolator technology, and digital monitoring. Discover how Annex 1, complex injectables, and supply resilience are shaping next-generation pharma production. Read more: pharmafocuseurope.com/articl… #Pharma #SterileAPI

Continuous manufacturing is reshaping pharma with potential cost savings, real-time quality control, and stronger supply resilience. How can strategic investments help European manufacturers stay competitive? Read more: pharmafocuseurope.com/articl… #Pharma #Manufacturing

How can digital innovation strengthen pharmaceutical R&D in Europe? AI, connected data, and smarter clinical trials offer opportunities to improve efficiency, reduce attrition, and accelerate drug development. Read more: pharmafocuseurope.com/articl… #Pharma #DigitalHealth

How do GMP systems and quality control shape pharmaceutical manufacturing in Europe? Discover how robust quality management supports compliance, product consistency and patient safety. 🔗 pharmafocuseurope.com/articl… #GMP #Pharma #QualityControl

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

From process development to GMP execution, effective handoffs can make a difference. Learn how biopharma teams can strengthen readiness and reduce challenges before clinical manufacturing begins. pharmafocuseurope.com/promot… #GMP #Biopharma #CDMO #DrugDevelopment